pattern image for icons

IMPERATIVE CARE
 LEADERSHIP

Imperative Care is led by an accomplished executive team with deep industry experience from over 30 global public and private companies.
Fred Khosravi
Fred Khosravi
Chairman and CEO
Chuck Alpuche
COO
Todd-Van-Horn-Headshot
Todd Van Horn
CFO
Carole Roth
Carole Roth
CPO
Nora Hadding
Nora Hadding
EVP, Regulations and Compliance
Scott Elliott
Scott Elliott
CLO
Ariel Sutton
Ariel Sutton
GM, Stroke
Daniel Davis
CSO
Doug Boyd
Doug Boyd
SVP and GM, Vascular
Richard Lepamentier
Richard Leparmentier
CTO, Imperative Care + GM, Robotics
Peter Griffin
Peter Griffin
SVP, Operations
Emir Deljkich
SVP, Clinical Affairs
Emir Deljkich
SVP, Clinical Affairs

Emir joined Imperative Care in 2020. He has over two decades of experience in product development, clinical research, and medical affairs for both start-ups and public companies in the medical device and biotechnology industries. Previously, Emir led Auris Health’s (acquired by Johnson & Johnson [JNJ]) robotic surgery clinical strategy and programs. Prior to joining Auris, Emir was Medical Director of CareDx (CDNA), where he was responsible for the publication strategy and execution of multiple clinical trials. During his tenure at EndoGastric Solutions, Emir held various leadership positions within clinical and medical affairs and was instrumental in obtaining a new CPT code for the Company’s novel endoluminal procedure. Earlier in his career, he held leadership positions at early-stage and venture-backed private companies (Sonitus Medical, RODO Medical, Spine Align) where he managed prototype development and early clinical efforts. Emir started his medical device career at Align Technology (ALGN) pre-IPO, where he held various key R&D and clinical affairs leadership positions. Emir received his MD from the University of Tuzla and completed the Clinical Trial Design and Management Program at San Francisco State University.

Fred Khosravi
Chairman
Imperative Care
Shacey Petrovic
Vice Chair
Insulet Corporation
Tyler Binney
Relievant Medsystems
Stacy Enxing Seng
Lightstone Ventures
Henrietta Fore
Holsman International
Andrew Hack, M.D., Ph.D.
Bain Capital
John J. Hamre, Ph.D.
Center for Strategic and International Studies (CSIS)
Hank Plain
Lightstone Ventures
Kevin Reilly
Ally Bridge Group
Holly Sheffield
CooperSurgical
Emir Deljkich
SVP, Clinical Affairs

Emir joined Imperative Care in 2020. He has over two decades of experience in product development, clinical research, and medical affairs for both start-ups and public companies in the medical device and biotechnology industries. Previously, Emir led Auris Health’s (acquired by Johnson & Johnson [JNJ]) robotic surgery clinical strategy and programs. Prior to joining Auris, Emir was Medical Director of CareDx (CDNA), where he was responsible for the publication strategy and execution of multiple clinical trials. During his tenure at EndoGastric Solutions, Emir held various leadership positions within clinical and medical affairs and was instrumental in obtaining a new CPT code for the Company’s novel endoluminal procedure. Earlier in his career, he held leadership positions at early-stage and venture-backed private companies (Sonitus Medical, RODO Medical, Spine Align) where he managed prototype development and early clinical efforts. Emir started his medical device career at Align Technology (ALGN) pre-IPO, where he held various key R&D and clinical affairs leadership positions. Emir received his MD from the University of Tuzla and completed the Clinical Trial Design and Management Program at San Francisco State University.